FI885838A - Foerfarande foer framstaellning av tioformamidderivat. - Google Patents
Foerfarande foer framstaellning av tioformamidderivat. Download PDFInfo
- Publication number
- FI885838A FI885838A FI885838A FI885838A FI885838A FI 885838 A FI885838 A FI 885838A FI 885838 A FI885838 A FI 885838A FI 885838 A FI885838 A FI 885838A FI 885838 A FI885838 A FI 885838A
- Authority
- FI
- Finland
- Prior art keywords
- naphthylmethyl
- thieno
- pyridin
- pyrid
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Cold Air Circulating Systems And Constructional Details In Refrigerators (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB878729521A GB8729521D0 (en) | 1987-12-18 | 1987-12-18 | New compositions of matter |
Publications (2)
Publication Number | Publication Date |
---|---|
FI885838A0 FI885838A0 (fi) | 1988-12-16 |
FI885838A true FI885838A (fi) | 1989-06-19 |
Family
ID=10628682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI885838A FI885838A (fi) | 1987-12-18 | 1988-12-16 | Foerfarande foer framstaellning av tioformamidderivat. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0321274B1 (fi) |
JP (1) | JPH01211566A (fi) |
KR (1) | KR890009871A (fi) |
AT (1) | ATE103596T1 (fi) |
AU (1) | AU2692888A (fi) |
DE (1) | DE3888806T2 (fi) |
DK (1) | DK703988A (fi) |
ES (1) | ES2053775T3 (fi) |
FI (1) | FI885838A (fi) |
GB (1) | GB8729521D0 (fi) |
HU (1) | HU200443B (fi) |
IL (1) | IL88701A0 (fi) |
NZ (1) | NZ227359A (fi) |
OA (1) | OA09025A (fi) |
PH (1) | PH25105A (fi) |
PT (1) | PT89243B (fi) |
ZA (1) | ZA889421B (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8913865D0 (en) * | 1989-06-16 | 1989-08-02 | May & Baker Ltd | New compositions of matter |
AU5232690A (en) * | 1989-03-31 | 1990-11-08 | Rhone-Poulenc Sante | Thioformamide derivatives |
GB8907306D0 (en) * | 1989-03-31 | 1989-05-17 | May & Baker Ltd | New compositions of matter |
AU5712890A (en) * | 1989-06-16 | 1990-12-20 | Rhone-Poulenc Sante | New thioformamide derivatives |
US5276045A (en) * | 1989-06-16 | 1994-01-04 | Rhone-Poulenc Sante | Thioformamide derivative, process for its preparation, pharmaceutical composition thereof and treatment method |
GB9000342D0 (en) * | 1990-01-08 | 1990-03-07 | May & Baker Ltd | New compositions of matter |
GB9002879D0 (en) * | 1990-02-08 | 1990-04-04 | May & Baker Ltd | New compositions of matter |
GB9002848D0 (en) * | 1990-02-08 | 1990-04-04 | May & Baker Ltd | New compositions of matter |
JPH04211048A (ja) * | 1990-03-05 | 1992-08-03 | Mitsubishi Kasei Corp | チオカルバモイルアセトニトリル誘導体 |
EP0609442A4 (en) * | 1991-10-14 | 1995-02-08 | Eisai Co Ltd | THIOFORMAMIDE DERIVATIVE. |
WO1994024094A1 (en) * | 1993-04-13 | 1994-10-27 | Ciba-Geigy Ag | Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
FR2849773B1 (fr) * | 2003-01-15 | 2006-07-14 | Oreal | Composition capillaire contenant un 2-alkylidene aminooxy-acetamide, son utilisation pour stimuler la pousse des cheveux et/ou freiner leur chute |
JP4037887B2 (ja) * | 2003-01-15 | 2008-01-23 | ロレアル | 2−アルキリデンアミノオキシアセタミドを含むケア用またはメイクアップ用の組成物、毛髪またはまつ毛の成長を刺激し、および/またはそれらの喪失を遅らせるためのその使用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2100970B1 (fi) * | 1970-07-30 | 1975-08-01 | Fujisawa Pharmaceutical Co |
-
1987
- 1987-12-18 GB GB878729521A patent/GB8729521D0/en active Pending
-
1988
- 1988-12-15 ZA ZA889421A patent/ZA889421B/xx unknown
- 1988-12-16 PT PT89243A patent/PT89243B/pt not_active IP Right Cessation
- 1988-12-16 AU AU26928/88A patent/AU2692888A/en not_active Abandoned
- 1988-12-16 KR KR1019880016914A patent/KR890009871A/ko not_active Application Discontinuation
- 1988-12-16 DK DK703988A patent/DK703988A/da not_active Application Discontinuation
- 1988-12-16 JP JP63318315A patent/JPH01211566A/ja active Pending
- 1988-12-16 AT AT88311927T patent/ATE103596T1/de active
- 1988-12-16 IL IL88701A patent/IL88701A0/xx unknown
- 1988-12-16 NZ NZ227359A patent/NZ227359A/xx unknown
- 1988-12-16 FI FI885838A patent/FI885838A/fi not_active IP Right Cessation
- 1988-12-16 HU HU886479A patent/HU200443B/hu not_active IP Right Cessation
- 1988-12-16 ES ES88311927T patent/ES2053775T3/es not_active Expired - Lifetime
- 1988-12-16 OA OA59492A patent/OA09025A/xx unknown
- 1988-12-16 PH PH37930A patent/PH25105A/en unknown
- 1988-12-16 DE DE3888806T patent/DE3888806T2/de not_active Expired - Fee Related
- 1988-12-16 EP EP88311927A patent/EP0321274B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0321274B1 (en) | 1994-03-30 |
JPH01211566A (ja) | 1989-08-24 |
DE3888806T2 (de) | 1994-09-22 |
AU2692888A (en) | 1989-06-22 |
PH25105A (en) | 1991-02-19 |
GB8729521D0 (en) | 1988-02-03 |
NZ227359A (en) | 1990-09-26 |
ATE103596T1 (de) | 1994-04-15 |
FI885838A0 (fi) | 1988-12-16 |
EP0321274A1 (en) | 1989-06-21 |
DK703988D0 (da) | 1988-12-16 |
HU200443B (en) | 1990-06-28 |
KR890009871A (ko) | 1989-08-04 |
HUT49116A (en) | 1989-08-28 |
ZA889421B (en) | 1989-09-27 |
DE3888806D1 (de) | 1994-05-05 |
ES2053775T3 (es) | 1994-08-01 |
PT89243B (pt) | 1993-07-30 |
DK703988A (da) | 1989-06-19 |
PT89243A (pt) | 1989-12-29 |
OA09025A (en) | 1991-03-31 |
IL88701A0 (en) | 1989-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI885838A (fi) | Foerfarande foer framstaellning av tioformamidderivat. | |
DK491489A (da) | Imidazolinderivater samt fremgangsmaade til fremstilling deraf | |
GB1509074A (en) | Cephalosporin derivatives | |
FI92069C (fi) | Menetelmä uusien, farmaseuttisesti aktiivisten 1H,3H-pyrrolo/1,2-c/tiatsoli-7-karboksamidijohdannaisten valmistamiseksi | |
OA09024A (en) | Thioformamide derivatives | |
DK0519353T3 (da) | Indolizinderivater, fremgangsmåde til fremstilling deraf og farmaceutisk præparat, der indeholder derivaterne | |
ES8403912A1 (es) | Procedimiento de preparacion de un nuevo derivados de la tioformamida. | |
IL94748A0 (en) | Thioformamide derivatives,process for their preparation and pharmaceutical compositions containing them | |
AU624724B2 (en) | Pyrrolo(2,1-b)thiazole derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: MAY & BAKER LIMITED |